Search - tctmd.com

Displaying 321 - 340 of 344

Sort: Relevancy | Date

News Daily News

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

July 05, 2012

News Daily News

Renal Denervation: Treatment for Hypertension Captures Interventional Spotlight

June 05, 2012

News Industry News

Data Presented at ACC.12 Demonstrate that OrbusNeich’s Genous™ Stent is Feasible and Safe in STEMI Patients

March 27, 2012

News Daily News

HORIZONS-AMI: Radial Access PCI Reduces Bleeding, MACE in STEMI

March 07, 2012

News Conference News

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

November 13, 2011

News Conference News

Ongoing Trials Explore Potential Benefits of Transradial PCI

November 08, 2011

News Daily News

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

October 31, 2011

News Daily News

Bivalirudin Decreases Bleeding Regardless of Heparin Anticoagulation Level

Yael L. Maxwell

October 13, 2011

News Daily News

Interruption of Antiplatelet Therapy Unnecessary for Tooth Extraction

July 27, 2011

News Daily News

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Jason Kahn

July 25, 2011

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Jason Kahn

June 13, 2011

News Daily News

Syntax Score Predicts 1-Year Risk in ACS Patients

June 06, 2011

News Daily News

Switching to Bivalirudin Effective After Early Heparin Therapy in STEMI Patients

May 31, 2011

News Daily News

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

L.A. McKeown

April 15, 2011

News Daily News

Aspirin’s GI Bleeding Risk Increased by Concomitant Use of Gastrotoxic Drugs

Caitlin E. Cox

March 10, 2011

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2010

Jason Kahn

January 02, 2011

Video

» Interview

STOPDAPT-2 ACS: Clopidogrel Monotherapy After 1 Month in ACS

August 30, 2021

Video

» Interview

HOST-EXAM: Aspirin vs Clopidogrel During Chronic Maintenance Monotherapy After PCI

May 20, 2021

Video

» Interview

TICO-STEMI: A Randomized Trial of Ticagrelor Monotherapy vs Ticagrelor With Aspirin in STEMI

October 14, 2020

CME

Advertisement

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

Renal Denervation: Treatment for Hypertension Captures Interventional Spotlight

Data Presented at ACC.12 Demonstrate that OrbusNeich’s Genous™ Stent is Feasible and Safe in STEMI Patients

HORIZONS-AMI: Radial Access PCI Reduces Bleeding, MACE in STEMI

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

Ongoing Trials Explore Potential Benefits of Transradial PCI

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

Bivalirudin Decreases Bleeding Regardless of Heparin Anticoagulation Level

Interruption of Antiplatelet Therapy Unnecessary for Tooth Extraction

Apixaban Increases Major Bleeding in High-Risk ACS Patients

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Syntax Score Predicts 1-Year Risk in ACS Patients

Switching to Bivalirudin Effective After Early Heparin Therapy in STEMI Patients

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

Aspirin’s GI Bleeding Risk Increased by Concomitant Use of Gastrotoxic Drugs

TCTMD’s Top 10 Most Popular News Stories for 2010

STOPDAPT-2 ACS: Clopidogrel Monotherapy After 1 Month in ACS

HOST-EXAM: Aspirin vs Clopidogrel During Chronic Maintenance Monotherapy After PCI

TICO-STEMI: A Randomized Trial of Ticagrelor Monotherapy vs Ticagrelor With Aspirin in STEMI

Optimizing the Duration of DAPT following PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content